Clinical Trials Directory

Trials / Completed

CompletedNCT04184401

Effect of Ascites Replacement Strategy on Time to 1st Flatus After LDLT

Effect of Albumin Administration Strategy for Ascites Replacement on Time to 1st Flatus After Liver Transplantation

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
72 (actual)
Sponsor
Seoul National University Hospital · Academic / Other
Sex
All
Age
19 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to evaluate difference in the rate of recovery of intestinal motility according to different ascites replacement strategy after living donor liver transplantation.

Conditions

Interventions

TypeNameDescription
DRUGAscites replacement with albumin and hartmann's solutionCombined strategy for ascites replacement * 30% of ascites: replacement with 5% albumin * 40% of ascites: replacement with Hartmann's solution
DRUGAscites replacement with hartmann's solutionHartmann's solution only strategy for ascites replacement \- 70% of ascites: replacement with Hartmann's solution

Timeline

Start date
2020-01-01
Primary completion
2021-11-30
Completion
2021-11-30
First posted
2019-12-03
Last updated
2023-07-12

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT04184401. Inclusion in this directory is not an endorsement.

Effect of Ascites Replacement Strategy on Time to 1st Flatus After LDLT (NCT04184401) · Clinical Trials Directory